TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bioform AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,031
|
1,892
|
1,126 |
| Financial expenses |
20
|
12
|
12 |
| Earnings before taxes |
791
|
771
|
72 |
| Total assets |
2,754
|
1,837
|
1,566 |
| Current assets |
2,081
|
1,522
|
1,341 |
| Current liabilities |
415
|
183
|
466 |
| Equity capital |
2,169
|
1,654
|
1,100 |
| - share capital |
59
|
62
|
66 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
78.8%
|
90.0%
|
70.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
38.9%
|
40.8%
|
6.4% |
| Return on assets (ROA) |
29.4%
|
42.6%
|
5.4% |
| Current ratio |
501.4%
|
831.7%
|
287.8% |
| Return on equity (ROE) |
36.5%
|
46.6%
|
6.5% |
| Change turnover |
236
|
838
|
-267 |
| Change turnover % |
13%
|
79%
|
-19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.